From: Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients
Diagnosis |  | N |  | Mean1 [LRG1] μg/ml |  | 95% CI |  | N |  | Mean Age |  | 95% CI |  | N |  | Log (CA125) |  | 95% CI |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Serous | Â | 79 | Â | 135.54 | Â | 121.30, 149.78 | Â | 79 | Â | 64.03 | Â | 61.36, 66.69 | Â | 74 | Â | 6.21 | Â | 5.87, 6.55 |
Clear Cell | Â | 8 | Â | 134.26 | Â | 91.59, 176.93 | Â | 8 | Â | 58.38 | Â | 50.00, 66.75 | Â | 8 | Â | 4.53 | Â | 3.49, 5.57 |
LMP | Â | 21 | Â | 91.11 | Â | 64.17, 118.05 | Â | 20 | Â | 51.40 | Â | 46.10, 56.70 | Â | 16 | Â | 4.62 | Â | 3.88, 5.35 |
Mucinous Cystadenoma | Â | 10 | Â | 94.31 | Â | 55.63, 132.98 | Â | 10 | Â | 45.60 | Â | 38.11, 53.09 | Â | 8 | Â | 3.35 | Â | 2.31, 4.39 |
Benign Ovarian Mass | Â | 30 | Â | 71.76 | Â | 47.18, 96.34 | Â | 27 | Â | 52.15 | Â | 47.59, 56.71 | Â | 25 | Â | 2.91 | Â | 2.32, 3.50 |
Cystadenoma | Â | 16 | Â | 73.06 | Â | 42.47, 103.65 | Â | 16 | Â | 53.00 | Â | 47.08, 58.92 | Â | 14 | Â | 3.21 | Â | 2.43, 4.00 |
Endometriosis | Â | 19 | Â | 87.49 | Â | 59.06, 115.93 | Â | 19 | Â | 43.11 | Â | 37.67, 48.54 | Â | 18 | Â | 4.25 | Â | 3.56, 4.94 |
Fibroma | Â | 10 | Â | 88.23 | Â | 50.28, 126.17 | Â | 10 | Â | 63.20 | Â | 55.71, 70.69 | Â | 9 | Â | 3.50 | Â | 2.52, 4.48 |
Total | Â | 193 | Â | Â | Â | Â | Â | 189 | Â | Â | Â | Â | Â | 172 | Â | Â | Â | Â |